Optimizing Patient Outcomes with JAK Inhibitors

Brett King, M.D, Ph.D and Alexandra Golant, M.D summarize their thoughts on optimizing treatment outcomes for patients suffering from atopic dermatitis with the JAK inhibitor class.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.